(Q33826397)

29 July 2017

1 reference

title

Circulating IGF-I and its protective role in the pathogenesis of diabetic angiopathy (English)

1 reference

29 July 2017

Janssen JA

1

1 reference

29 July 2017

Lamberts SW

series ordinal

2

1 reference

29 July 2017

publication date

1 January 2000

1 reference

29 July 2017

published in

Clinical Endocrinology

1 reference

29 July 2017

volume

52

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

1-9

1 reference

Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Diabetic retinopathy: early functional changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Growth during childhood and final height in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Self monitoring of glucose by people with diabetes. Patients with non-insulin dependent diabetes should monitor urine urine rather than blood glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Insulin-like growth factor-I and insulin-like growth factor binding protein-1 in a representative population of type 2 diabetic patients in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Insulin-like growth factor binding proteins and their role in controlling IGF actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Elevated plasma insulin-like growth factor binding protein-1 levels in type 1 (insulin-dependent) diabetic patients with peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Worsening of diabetic retinopathy after improvement of glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Insulin-like growth factors (IGFs) and IGF-I treatment in the adolescent with insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Growth factors and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Free insulin-like growth factors (IGF-I and IGF-II) in human serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Effects of aging on insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Hyperoxia improves contrast sensitivity in early diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Improvements and new potentials in pharmacological therapy of diabetes mellitus in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

A population-based study of diabetic retinopathy in insulin-using patients diagnosed before 30 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Survival following alpha particle pituitary irradiation for diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Epidemiology of late diabetic complications. A basis for the development and evaluation of preventive programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Diabetes mellitus and sexual ateliotic dwarfism: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Diabetic retinopathy. A synthesis of perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Glomerular hyperfiltration in human diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Does IGF-I therapy in insulin-dependent diabetes mellitus limit complications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Aging is associated with decreased suppression of insulin-like growth factor binding protein-1 by insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Insulin-like growth factor-I and diabetes. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Ocular blood flow and associated functional deviations in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

Serum insulin-like growth factor I levels in adult diabetic patients: the effect of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

rhIGF-I Administration Reduces Insulin Requirements, Decreases Growth Hormone Secretion, and Improves the Lipid Profile in Adults With IDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

The relationship between overnight GH levels and insulin concentrations in adolescents with insulin-dependent diabetes mellitus (IDDM) and the impact of recombinant human insulin-like growth factor I (rhIGF-I)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

ORCADIAN VARIATION OF GH-INDEPENDENT IGF-BINDING PROTEIN IN DIABETES MELLITUS AND ITS RELATIONSHIP TO INSULIN. A NEW ROLE FOR INSULIN?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

THE GROWTH HORMONE INDEPENDENT INSULIN-LIKE GROWTH FACTOR-I BINDING PROTEIN BP-28 IS ASSOCIATED WITH SERUM INSULIN-LIKE GROWTH FACTOR-I INHIBITORY BIOACTIVITY IN ADOLESCENT INSULIN-DEPENDENT DIABETICS

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00922.X

10.1046/J.1365-2265.2000.00922.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference